| Mrs Heather Nicole Salo, DPT | |
|
3718 E Lake Dr, Butte, MT 59701-4388 | |
| (406) 565-5085 | |
| (833) 406-2356 |
| Full Name | Mrs Heather Nicole Salo |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 3718 E Lake Dr, Butte, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164819124 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PTP-PT-LIC-4355 (Montana) | Primary |
| Provider Name | Butte Orthopedic And Fracture Clinic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326146556 PECOS PAC ID: 6608761416 Enrollment ID: O20040219000943 |
News Archive
Computer scientists have been working for decades on automatic navigation systems to aid the visually impaired, but it's been difficult to come up with anything as reliable and easy to use as the white cane, the type of metal-tipped cane that visually impaired people frequently use to identify clear walking paths.
Supported by a National Institutes of Health grant worth a projected $3.3 million over five years, Wake Forest Baptist Medical Center investigators have expanded their research into the cumulative effects of head impacts in young football players to the high school level.
The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).
Patients in the UK who have survived critical illnesses requiring care in an intensive care unit (ICU) frequently report symptoms of anxiety, PTSD and/or depression, according to a study published in open access journal Critical Care.
BioLineRx, a biopharmaceutical development company, announced today that it intends to conduct an interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
› Verified 7 days ago
| Provider Name | Advanced Therapy Clinic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265898696 PECOS PAC ID: 9032451687 Enrollment ID: O20190430002453 |
News Archive
Computer scientists have been working for decades on automatic navigation systems to aid the visually impaired, but it's been difficult to come up with anything as reliable and easy to use as the white cane, the type of metal-tipped cane that visually impaired people frequently use to identify clear walking paths.
Supported by a National Institutes of Health grant worth a projected $3.3 million over five years, Wake Forest Baptist Medical Center investigators have expanded their research into the cumulative effects of head impacts in young football players to the high school level.
The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).
Patients in the UK who have survived critical illnesses requiring care in an intensive care unit (ICU) frequently report symptoms of anxiety, PTSD and/or depression, according to a study published in open access journal Critical Care.
BioLineRx, a biopharmaceutical development company, announced today that it intends to conduct an interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Heather Nicole Salo, DPT Po Box 4464, Butte, MT 59702-4464 Ph: (406) 565-5085 | Mrs Heather Nicole Salo, DPT 3718 E Lake Dr, Butte, MT 59701-4388 Ph: (406) 565-5085 |
News Archive
Computer scientists have been working for decades on automatic navigation systems to aid the visually impaired, but it's been difficult to come up with anything as reliable and easy to use as the white cane, the type of metal-tipped cane that visually impaired people frequently use to identify clear walking paths.
Supported by a National Institutes of Health grant worth a projected $3.3 million over five years, Wake Forest Baptist Medical Center investigators have expanded their research into the cumulative effects of head impacts in young football players to the high school level.
The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).
Patients in the UK who have survived critical illnesses requiring care in an intensive care unit (ICU) frequently report symptoms of anxiety, PTSD and/or depression, according to a study published in open access journal Critical Care.
BioLineRx, a biopharmaceutical development company, announced today that it intends to conduct an interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
› Verified 7 days ago
Southwest Montana Veterans Home Physical Therapist Medicare: Medicare Enrolled Practice Location: 65 Veterans Circle, Butte, MT 59701 Phone: 406-792-3100 | |
Desiree Van Blaricom, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 435 S Crystal St, Ste 400, Butte, MT 59701 Phone: 406-496-3456 Fax: 406-496-3457 | |
Copper Ridge Nursing And Rehab Center Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 3251 Nettie St, Butte, MT 59701 Phone: 801-601-1450 | |
Mrs. Ajkena Coate, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3251 Nettie St, Butte, MT 59701 Phone: 406-939-4353 | |
Melissa Joy Swanson, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 120 Foxtail Lane, Butte, MT 59701 Phone: 406-490-3634 | |
Anna B Wherry, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 524 E Park St, Butte, MT 59701 Phone: 406-782-4748 Fax: 406-782-4375 | |
Holly Ferguson I, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-723-2522 Fax: 406-723-2544 |